Sugemalimab, CAS [[2256084-03-2]]

Produktübersicht

• Artikelname: Sugemalimab, CAS [[2256084-03-2]]
• Artikelnummer: TGM-T76714
• Hersteller Artikelnummer: T76714
• Alternativnummer: TGM-T76714-1MG,TGM-T76714-5MG,TGM-T76714-10MG,TGM-T76714-25MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Sugemalimab (CS1001) is a fully humanized, full-length monoclonal antibody targeting PD-L1. It cross-links PD-L1-positive tumor cells with macrophages, inducing antibody-dependent cellular cytotoxicity. Sugemalimab is being studied for EGFR mutation-negative and ALK-negative metastatic non-small cell lung cancer (NSCLC), advanced solid tumors, and lymphoma.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [2256084-03-2]
• Target-Kategorie: PD-1/PD-L1